The varieties of infections caused by Helicobacter pylori may be due to differences in bacterial genotypes and virulence factors as well as environmental and host-related factors. This study aimed to investigate the prevalence of cagA and vacA genes among H. pylori-infected patients in Iran and analyze their relevance to the disease status between two clinical groups via a meta-analysis method. Different databases including PubMed, ISI, Scopus, SID, Magiran, Science Direct, and Medlib were investigated, and 23 relevant articles from the period between 2001 and 2012 were finally analyzed. The relevant data obtained from these papers were analyzed by a randomeffects model. Data were analyzed using R software and STATA. The prevalence of cagA and vacA genes among H. pylori-infected patients was 70% (95% CI, 64-75) and 41% (95% CI, 24.3-57.7), respectively. The prevalence of duodenal ulcers, peptic ulcers, and gastritis among cagA+ individuals was 53% (95% CI, 20-86), 65% (95% CI, 34-97), and 71% (95% CI, 59-84), respectively. Odds ratio (OR) between cagA-positive compared with cagA-negative patients showed a 1.89 (95% CI, 1.38-2.57) risk of ulcers. In conclusion, the frequency of cagA gene among H. pylori strains is elevated in Iran and it seems to be more frequently associated with gastritis. Therefore, any information about cagA and vacA prevalence among different H. pylori-infected clinical groups in the country can help public health authorities to plan preventive policies to reduce the prevalence of diseases associated with H. pylori infection.
Introduction
Helicobacter pylori infection is a prevalent disease that affects more than half of the world's population. It is the most common infectious bacteria of the stomach and can persist in many conditions in which other bacteria are not able to live [1] . H. pylori is a Gramnegative and microaerophilic bacillus that is recognized as a special pathogen of the human stomach. It causes a chronic inflammation of gastric mucosa by infiltration of neutrophils, lymphocytes, and plasma cells into the gastric mucosa. This bacillus is the etiological cause of peptic ulcers, adenocarcinoma of stomach, and MALT lymphoma, and has been associated with ischemic heart disease, adenotonsillar disease, and other types of malignancies [1] [2] [3] [4] . H. pylori is able to colonize the human gastric mucosa and create a persistent infection associated with acute or chronic inflammation [5] . Mucosal gastritis occurs in all infected patients; however, only a small number of these patients show clinical symptoms and relevant complications such as peptic ulcers, gastritis, or gastric cancer [6] . Contamination with H. pylori in developing countries is high, and a prevalence of more than 80% has been reported. Also, the severity of H. pylori-dependent gastro-duodenal diseases is influenced by bacterial, environmental, and genetic factors [2] . The relevant mechanisms involved in different aspects of the diseases have not been fully elucidated yet; however, a combination of different virulence factors in different H. pylori strains may play a role [6] . Nevertheless, the cytotoxin-associated gene A (cagA) and the vacuolating cytotoxin (vacA) are the two main H. pylori virulence factors identified among the bacterial markers associated with pathogenesis of different strains [6] .
Mounting evidence indicates a positive relationship between the presence of H. pylori cagA+ strains and the development of peptic/duodenal ulcers and gastric cancer in infected patients [5] .
H. pylori cagA+ strains carry a 40 kbp pathogenicity island, which contains the cagA gene that encodes cagA and genes that encode a type IV secretion system, through which cagA and other bacterial virulence factors are injected into host cells [7] . The cagA gene is present in about 50%-70% of strains, and in some Asian countries, its prevalence is about 90% [2] . According to variation seen at its tyrosine phosphorylation-SHP-2 binding site, cagA has been sub-classified in two main types, Western cagA and East Asian cagA, the latter being more biologically active and accounting for the high incidence of gastric carcinoma in East Asian countries [7] . After injection into host epithelial cells, cagA is tyrosine phosphorylated and activates the Ras-MAPK (mitogen-activated protein kinase) kinase pathway. This induces cell growth and motility of gastric epithelial cells along with alteration of epithelial cell differentiation [7] .
VacA is an 88 kDa protein toxin that was identified by its ability to induce the formation of cytoplasmic vacuoles in cultured cells [8] . It has been suggested that VacA acts as a multifunctional toxin. Indeed, VacA has been reported to induce cell damage of gastric epithelial cells and to exert an immunosuppressive action through inhibition of antigen presentation and T-lymphocyte activation. Although the gene encoding VacA (vacA) is present in all H. pylori strains, allele variations exist in the VacA secretion signal sequence (allele types s1 or S1) and the mid-region (alleles types m1 or m2) [9] .
The isolates carrying vacA and cagA create more severe inflammation. There are many studies, with different findings, about the existence or absence of cagA and its treatment [3] . According to different studies, isolates possessing cagA increase the risk of special clinical aspects, but their incidences are not predictable [6] .
This study aimed to investigate the prevalence of cagA and vacA among H. pylori-infected patients developing peptic ulcer disease (PUD), non-ulcer disease (NUD), gastritis, and gastric cancer in Iran using a meta-analysis method.
Methodology

Search method
All associated published papers in national and international journals of PubMed, Scopus, ISI, Magiran, IranMedex, Science Direct, Medlib, and SID databases were evaluated. Searching was done in a systematic way using keywords cagA, vacA, prevalence, H. pylori, Iran, and meta-analysis (both in English and Persian).
Paper selection
First, a list of 67 papers and abstracts yielded by the keyword search, was prepared and evaluated for relevance. Of these studies, 17 were excluded because they were repetitive, 8 were not consistent with the study criteria, the full texts of 11 papers were not accessible and their abstracts did not contain enough information, and 8 papers did not reveal the prevalence of cagA; all of these papers were withdrawn (Flowchart 1). Finally, 23 relevant papers [2] [3] [4] 6, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] were identified. Their data were entered into the data collection forms, and then these data were entered into Microsoft Excel and were analyzed using R software (version 11.2) and STATA (version 10).
Statistical analysis
The main objective of the study was to evaluate the prevalence of cagA and vacA; therefore, its variance was estimated by binominal distributions. To pool prevalence reported by different studies, weighting averaging was used. Each study was given a weight equal to its inverse variance. For evaluation of heterogeneity, Q test and I 2 index, at the type I error of smaller than 0.10, were applied. Wherever the results of studies were heterogeneous, the analysis was performed using a random-effects model. The randomFlowchart 1. The flowchart of selected articles for final analysis effects model was used because there was significant heterogeneity among the results of the studies (I 2 = 92%, p = 0.000). To pool the results of the studies, two main approaches were used: the fix effects model and the random-effects model. When heterogeneity among the results of the studies was not significant, the fix effects model was used to pool analysis and verses. In a two-by-two cross-sectional table, odds ratio was (OR) computed using the formula: = The 95% confidence interval (CI) was computed using the formula:
That:
Funnel plot is a graphical detection of publication bias. The funnel plot is a bivariate scatter plot (x, y) of the study sample size against the study estimate of treatment difference or effect size. There is a formal test for publication bias based on linear regression analysis. It includes both intercept and slope parameters and is given by y i = α + βx i + ε i , for i = 1, . . . , r, where r is the number of studies, y i is the standardized estimate, x i is the precision of studies, and ε i is the error terms. respectively. In 11 studies, the prevalence of cagA among patients with PUD and those with NUD was analyzed ( Figure 3 ). Patients with positive cagA compared to those with negative cagA showed risk of peptic ulcer of 1.89 (95% CI, 1.38-2.57) ( Table 2) . A statistically significant relationship between cagA positivity and H. pylori infection was found when data of all eleven studies were combined. The prevalence of duodenal ulcers (reported by six studies), peptic ulcers (reported by six studies), and gastritis (reported by six studies) among individuals infected with H. pylori cagA+ strains was 53% (95% CI, 20-86), 65% (95% CI, 34-97), and 71% (95% CI, 59-84), respectively. According to the publication bias figure, the effect of bias in these studies was not significant. In fact, most studies were located inside the funnel plot, thus demonstrating that the results of most relevant studies performed in Iran were included in the analysis (Figure 4) . Interpretation of meta-regression showed that there was no significant relationship between prevalence of cagA and the year of study (p = 0.57) ( Table 3 ).
Discussion
The current meta-analysis study evaluated the prevalence of cagA and vacA in a total sample size of 3,011 patients infected with H. pylori in Iran between 2001 and 2012. In the current study, the prevalence of cagA among patients infected with H. pylori was 70%, which was in accordance with reports from Iraq (71%) and Turkey (78%) [25, 29] . It was also consistent with reports from Europe and North America [30, 34] . However, the prevalence obtained from the present study was lower than that reported from Southeast Asia (93% positive for cagA) by a similar metaanalysis study [35] . Podzorski et al. from the United States reported that only 66% of H. pylori isolates were positive for cagA [36] . Zhou et al. from China reported a prevalence of 93.9% for cagA among H. pylori isolates [37] ; however, this figure for the Netherlands, Germany, Estonia, and Sri Lanka was 46%, 87.2%, 87%, and 45%, respectively [38] . A study from Brazil reported a prevalence of 81.7% for the cagA gene among H. pylori isolates [39] . There is a variety in the distribution of cagA among H. pylori isolates in different parts of the world [40] . According to evidence, more than 90% of isolates form Eastern populations included cagA [41] . The prevalence found in the current study was different from that reported from South and East Asian countries, in which a prevalence of more than 90% was reported [42, 43] . For example, a prevalence of 97%, 95%, 94%, and 90% was reported for cagA among H. pylori isolates from Korea, Japan, Malaysia, and China, respectively [44] [45] [23] [24] . Our findings were more similar to those reported from European and American countries that ranged between 60% and 70% [46] . In partial support of this, a recent study showed that H. pylori isolates from infected patients in Iran displayed a large variability in the polymorphisms of cagA and vacA genes [47] . This may be due to the location of this country in the Middle East; it may have a combination of Western and Eastern isolates of H. pylori [47] .
CagA pathogenicity island of is one of the most important markers of H. pylori pathogenesis, so isolates without this island have lower abilities for pathogenesis. The cagA gene is the biggest segment of this island; therefore, the presence of the cagA gene can be an existence marker of this island [19] . The prevalence of isolates with cagA among different geographical areas is also different, which may be related to the difference between studied populations and/or genetic varieties of investigated isolates. This finding of our study was in accordance with reports from East Asian countries [48] .
A previous meta-analysis study demonstrated that the prevalence of H. pylori infection in Iran was 50.7% (95% CI, 44.4-56.9) [49] . The frequencies of peptic ulcers and gastric malignancy are highly affected by ethnical and geographical variables; therefore, these findings combined with the lower efforts for H. pylori eradication in Iran as well as a considerable of recurrent infections may indicate a high developmental process of Iranian isolates [11] .
Mounting evidence demonstrates that the genetic variability of H. pylori strains is dependent on the geographical and ethnic status of human hosts [11] . A study by Latifi et al. analyzed the sequences of housekeeping genes and revealed that genetic characteristics of H. pylori in Iran were affected by genetic interchanges with neighboring countries, and that there were considerable ethnical and geographical differences inside Iran [50] .
This finding was in accordance with our results about differences in the local prevalence of cagA obtained from Tehran (71%), Shiraz (65%), Babol (80%), Isfahan (44%), Shahrkord (92%), Shahroud (75%), Golestan (58%), and Tabriz (76%). Internal studies on the cagA gene in Iran showed contradictory results; in some studies, the difference between reported prevalence of cagA was more than 50%. One of the reasons for these contradictory results was the different sensitivities of the methods used for identification of cagA and H. pylori infections in different studies [51] [52] [53] . H. pylori has been confirmed as an important pathogen in the human gastric tract, and different isolates of these bacteria cause a variety of gastrointestinal disorders resulting in complications such as injury of gastric mucosa, transformation of tissue stratum, chronic inflammation, chronic gastritis, PUD, and gastric malignancy. However, not all involved patients suffer from these complications, and more than 50% of involved patients do not show any symptoms. Genetic pathogenesis of different isolates and environmental characteristics are essential factors related to this discrepancy [6, 24] . CagA as a product of the cagA gene has been introduced as the main pathogen factor in H. pylori and acts as a provoker for different disorders related to this microorganism. The effects of CagA in the induction of local inflammatory response, progress of PUD, and gastric malignancy have been recognized [52, 64] . Our study showed a higher frequency of patients with cagA among patients with PUD compared to those with NUD. It has been reported that patients with NUD are more resistant to H. pylori-eradication therapy than individuals with PUD. Additionally, there is some influence of cagA status on eradication in NUD patients, a possibility which warrants further investigation given the link between cagA status and improvement of symptoms in NUD patients in whom eradication is successful [55] ; however, this difference was found not to be significant. Almost all previous studies have shown a higher frequency of positive cagA among patients with PUD compared to those with NUD; however, these differences were statistically significant in only some of these studies [56] [57] [58] (inconsistent with our results) and not significant in others [59] [60] [61] (consistent with our results). In further support of a correlation between cagA positivity and PUD, it has been demonstrated that cytotoxic cagA-positive strains cause more profound inhibition of mucin synthesis, thus suggesting that the increased inhibitory effect of cagApositive, cytotoxin-producing strains on mucin synthesis increases the risk of developing peptic ulceration [48] .
In the populations of Western countries, particular genotypes of the vacuolating cytotoxin gene vacA (vacA s, signal region variants; vacA m, middle region variants) of H. pylori have been associated with high risk of developing peptic ulcers and gastric cancer [62] .
In the current study, the prevalence of duodenal ulcers, peptic ulcers, and gastritis among patients with positive cagA was 53%, 65%, and 71%, respectively. In previous studies, the presence of cagA was associated with severe gastric disorders such as severe gastritis, duodenal ulcers, peptic ulcers, and gastric malignancy [63] [64] [65] . Our findings, similar to these studies, showed high frequency of these disorders among patients with cagA. Aydin et al. reported a prevalence of 72.2% cagA among isolates detected from patients with peptic ulcers in Turkey [66] . Figueredo and colleagues reported a prevalence of 56%, 90%, 88%, and 88% of cagA among isolates detected from patients with gastritis, duodenal ulcers, peptic ulcers, and gastric cancer, respectively [67] . Arents et al. showed a higher prevalence in the Netherlands of cagA among patients with peptic ulcers compared with patients with other diseases [68] . Also, other studies from Iraq [25] , Turkey [29] , and Saudi Arabia [69] reported a relationship between the cagA gene and gastric cancer or peptic ulcers. A study from Italy demonstrated that the prevalence of the cagA gene among patients with duodenal ulcers and peptic ulcers was 86.1% and 96.4%, respectively [70] . Gzyl et al. reported a positive relationship between cagA gene and incidence of acute gastritis among child and adult patients [71] . According to different reports, either numbers or features of different motifs are changed by alteration of geographical locations, and their clinical outcomes are also affected by this variation. Western Asian isolates are therefore different from Eastern Asian isolates [11] , and Eastern Asian isolates are more associated with gastric cancer than are Western isolates [72] . For example, studies by Zhou et al. [37] and Chen et al. [57] reported the prevalence of cagA among isolates associated with peptic ulcers and gastric cancers to be 100% and 94%, respectively. Some studies from Western countries reported a relationship between severity of diseases and the prevalence of cagA among associated isolates, but studies from East Asia reported no significant relationship between these variables [73] [74] and concluded that clinical results could not be predicted by the prevalence of cagA among Asian countries [75] [76] . Moreover, meta-analyses identified a significant relationship between vacA m-region genotype and cagA status and the development of diseases in Southeast Asia. Importantly, most of the H. pylori strains isolated from countries with high incidences of gastric cancer and anti-cagA antibody can be used as a biomarker for gastric cancer even in East Asian countries [55, [77] [78] .
Our study showed higher frequency of the cagA gene among patients with gastritis, but this was not statistically significant. Despite the difference in the frequency of cagA among different types of diseases, a relationship between the presence or absence of cagA and the severity of disease can be assumed. The current study showed that more than 70% of Iranian isolates were positive for cagA. High frequency of cagA among isolates does not necessarily lead to severe diseases such as severe gastritis, peptic ulcers, or gastric cancer; however, this finding may be due to excess numbers of alleles among cagA genes in Iranian isolates.
Discrepancies between different reports about the severity of immune responses and the incidence of clinical outcomes for isolates with positive cagA may be associated with environmental and genetic factors of either host or bacteria. Examples for these are gene polymorphisms of inflammatory cytokines, difference in individual immune systems, and genetic differences in bacterial virulence genes such as vacA, iceA, and several genes included in the cag pathogenicity island [79] [80] Polymorphisms in interleukin (IL)-1B, IL-1RN, IL-8, IL-10, and tumor necrosis factor alpha (TNF-α), which are involved in H. pylori infection, increase risk of gastric cancer [81] [82] .
Despite the relationship of these well-known genes with clinical outcomes, it seems this subject is still a controversial problem; for clarity of this ambiguity, execution of studies with bigger sample sizes and in different geographical places of Iran is suggested [10] . Some limitations of this study were the lack of comparison between the prevalence of cagA gene and age/gender groups of patients; the lack of comparison between peptic ulcers and age/gender groups; and the unavailability of some studies associated with prevalence of cagA.
Conclusions
Considering the high prevalence of H. pylori infection and its serious outcomes, early diagnosis of this bacteria and characterization of cagA and vacA status of H. pylori strains using polymerase chain reaction (PCR) is important for the prevention and timely treatment of associated infection. In this study, we revealed a high prevalence of the cagA gene in Iran and a more significant correlation between cagA gene positivity in gastritis compared with other diseases. Due to dispersal uniformity of cagA genes among all disease groups, the presence of the cagA gene cannot be considered solely as a determinant marker of clinical outcome for H. pylori infection. Therefore, the clinical features of diseases associated with H. pylori infection are mostly related to bacterial, environmental, and host-related factors. Due to the complexity features of diseases associated with H. pylori infection, identification of new acutenessrelated factors and expansion of their monitoring in the different geographical areas is necessary.
